AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 16 filers reported holding AKARI THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 426,297 | $1,965,000 | 0.78% |
| Vivo Capital, LLC | 527,842 | $2,433,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,158 | $3,772,000 | 0.20% |
| NEA Management Company, LLC | 452,167 | $2,084,000 | 0.08% |
| Hikari Power Ltd | 60,012 | $277,000 | 0.04% |
| Baker Brothers Advisors | 496,901 | $2,291,000 | 0.02% |
| QVT Financial LP | 132,077 | $531,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 214,126 | $987,000 | 0.00% |
| Virtu KCG Holdings LLC | 12,472 | $57,000 | 0.00% |
| Advisor Group, Inc. | 6,381 | $29,000 | 0.00% |